| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Paul Rivard | Chief Legal Officer | $444K | Aug 24, 2023 | ||
| Joshua Silverman | Executive Chairman, Director | $780 | Oct 3, 2025 | ||
| Billy Joe White | Director | $196 | Oct 3, 2025 | ||
| Stephen Friscia | Director | $194 | Oct 3, 2025 | ||
| Mitchell Glass | Director, Chief Medical Off., Director | $97.00 | Oct 3, 2025 | ||
| Gary Rauch | Vice President of Finance | $97.00 | Oct 3, 2025 | ||
| Bruce Bernstein | Director | $2.00 | Sep 1, 2025 | ||
| PharmaCyte Biotech, Inc. | 10%+ Owner | May 23, 2024 | |||
| Christopher Chapman | President, Chief Med. Officer, Director | Jun 7, 2023 | |||
| Craig Eagle | Director | Jun 7, 2023 | |||
| Jude Uzonwanne | Director | Jun 7, 2023 | |||
| Christopher Schreiber | Director | Jun 7, 2023 | |||
| Adam Kaplin | Chief Scientific Officer | Jun 7, 2023 | |||
| Ian Rhodes | Interim CFO | Apr 17, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|